There’s no doubt that artificial intelligence (AI) and data science are among pharma’s biggest buzzwords at the moment, and Novartis AG is making a bid to become a sector leader in the fast-emerging technologies.
While some in the sector may have grown wary of the hype around AI, Novartis is pushing ahead in the...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?